| # | Drug | Count |
|---|---|---|
| 0 | CANAGLIFLOZIN | 1086 |
| 1 | INSULIN GLARGINE | 522 |
| 2 | ASPIRIN | 496 |
| 3 | ASPIRIN 325 MG | 485 |
| 4 | ASPIRIN 81 MG | 485 |
| 5 | INSULIN LISPRO | 374 |
| 6 | PREDNISONE | 370 |
| 7 | LISINOPRIL | 365 |
| 8 | METFORMIN | 355 |
| 9 | METFORMIN ER 500 MG | 355 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | COAL TAR | 181 | 0.2294 |
| 1 | CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 80 | 0.0441 |
| 2 | ACITRETIN | 186 | 0.0377 |
| 3 | CANAGLIFLOZIN | 1086 | 0.0364 |
| 4 | ALISKIREN HEMIFUMARATE | 172 | 0.0285 |
| 5 | METHYLPREDNISOLONE ACETATE | 182 | 0.0224 |
| 6 | DIMENHYDRINATE | 217 | 0.0202 |
| 7 | ESOMEPRAZOLE SODIUM | 40 | 0.0164 |
| 8 | SITAGLIPTIN PHOSPHATE | 43 | 0.0158 |
| 9 | PREDNISOLONE SODIUM PHOSPHATE | 32 | 0.0128 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 761 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 727 |
| 2 | Corticosteroid [EPC] | 600 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 501 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 322 |
| 5 | Proton Pump Inhibitor [EPC] | 320 |
| 6 | Loop Diuretic [EPC] | 305 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 300 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 289 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 282 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline [EPC] | 9 | 0.0096 |
| 1 | Phenothiazine [EPC] | 190 | 0.0063 |
| 2 | Provitamin D2 Compound [EPC] | 186 | 0.0063 |
| 3 | Anti-coagulant [EPC] | 20 | 0.0054 |
| 4 | alpha-1 Adrenergic Agonist [EPC] | 16 | 0.0036 |
| 5 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 6 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 7 | Phosphodiesterase 3 Inhibitor [EPC] | 20 | 0.0032 |
| 8 | Vitamin D2 Analog [EPC] | 22 | 0.0031 |
| 9 | 5-Lipoxygenase Inhibitor [EPC] | 2 | 0.0031 |